New Pharaoh CEO Amaza Reitmeier explains why now’s the time to take a leap and lead a CSF startup

About this episode

Amaza Reitmeier discusses her transition from Medtronic to leading Pharaoh Neuro and shares insights on career timing and MedTech opportunities.

In this episode of the DeviceTalks Weekly podcast, Amaza Reitmeier shares with Host Tom Salemi why she left the company she never thought she’d leave — Medtronic — to lead Pharaoh Neuro, a company developing a novel approach to treating stroke patients by removing harmful blood from cerebrospinal fluid. Reitmeier shares lessons from her own career and her mentors on timing big moves, learning what you don’t know, and why some of MedTech’s biggest opportunities remain hidden in plain sight. This episode is sponsored by DeviceTalks Minnesota. Register at Minnesota.DeviceTalks.com and use the code DTW25 to save 25% off the registration fee. Salemi and MassDevice Editor Chris Newmarker offer encouragement to exercising listeners while delivering this week’s Newmarker’s Newsmakers — including updates on cardiology companies, HistoSonics, Boston Scientific, Johnson & Johnson MedTech, Abbott, the Mayo Clinic, and WHOOP. *** Enjoy the show? Follow DeviceTalks Weekly on all major podcast players + Follow us on YouTube.com/@DeviceTalks to ensure you never miss an episode. Want access to the complete DeviceTalks Podcast Network (DTPN)? Follow us today at…

People in this episode

Host: Tom Salemi

Guest: Amaza Reitmeier

Topics covered

• leadership
• healthcare innovation
• stroke treatment
• MedTech opportunities
• career transitions

Keywords

• Pharaoh Neuro
• stroke treatment
• Medtronic
• career advice
• healthcare innovation
• MedTech
• Amaza Reitmeier

Sponsors

DeviceTalks Minnesota

Mentioned in this episode

Organizations: Medtronic, Pharaoh Neuro, MassDevice, HistoSonics, Boston Scientific, Johnson & Johnson MedTech, Abbott, Mayo Clinic, WHOOP

More episodes of DeviceTalks Podcast Network

• Intuitive's Hutton on Why the Surgical Robotics Leader Is Taking Aim at Cardiac Surgery Again · June 12, 2026 · 1h 2m
• Lisa Earnhardt on Abbott’s Innovation Strategy and the Future of Patient-Centered Care · June 5, 2026 · 1h 15m
• A Focused View of EDOF™ Technology from a GI Clinician · June 2, 2026 · 34 min
• DeviceTalks Boston Wrap Up with the Editors (and Many Special Guests!) · May 29, 2026 · 35 min
• Axoft is building a BCI success story in Massachusetts; MassMEDIC's Johnson on MedTech’s future · May 22, 2026 · 1h 8m
• High-Stakes Decision-Making is an Art – Boston Scientific, Cryosa, Provation · May 19, 2026 · 1h 8m